3,4-dihydroxyphenylacetic acid has been researched along with vinpocetine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Baba, J; Miyashiro, M; Sawa, A; Yamashita, N | 1 |
| Nekrassov, V; Sitges, M; Trejo, F | 1 |
| Aldana, BI; Chiu, LM; Nekrassov, V; Sitges, M | 1 |
5 other study(ies) available for 3,4-dihydroxyphenylacetic acid and vinpocetine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Rolipram, a selective inhibitor of phosphodiesterase type 4, pronouncedly enhanced the forskolin-induced promotion of dopamine biosynthesis in primary cultured rat mesencephalic neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Cells, Cultured; Colforsin; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Dopamine; Embryo, Mammalian; Female; Mesencephalon; Neurons; Phosphodiesterase Inhibitors; Pregnancy; Pyrrolidinones; Rats; Rats, Wistar; Rolipram; Vinca Alkaloids | 1997 |
Characterization of vinpocetine effects on DA and DOPAC release in striatal isolated nerve endings.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Calcium Channel Blockers; Carrier Proteins; Clorgyline; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Exocytosis; Male; Membrane Glycoproteins; Membrane Potentials; Membrane Transport Proteins; Monoamine Oxidase Inhibitors; Neostriatum; Nerve Tissue Proteins; Potassium; Presynaptic Terminals; Rats; Rats, Wistar; Reserpine; Sodium Channel Blockers; Sodium Channels; Synaptosomes; Veratridine; Vinca Alkaloids | 2001 |
Characterization of phenytoin, carbamazepine, vinpocetine and clorgyline simultaneous effects on sodium channels and catecholamine metabolism in rat striatal nerve endings.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anticonvulsants; Aspartic Acid; Carbamazepine; Catecholamines; Clorgyline; Corpus Striatum; Dopamine; Glutamine; In Vitro Techniques; Male; Monoamine Oxidase Inhibitors; Nerve Endings; Phenytoin; Rats; Rats, Wistar; Sodium Channel Agonists; Sodium Channels; Vinca Alkaloids | 2009 |